Annual Conference 2014

244 - Sorting Out PSA: Screening Smarter

Nov 2, 2014 1:15pm ‐ Nov 2, 2014 2:15pm

Standard: $20.00
Members: $0.00

Description

Targeted to advanced practice providers: PSA monitoring, indications for biopsy referral, effects of testosterone replacement on PSA and how to evaluate changes in PSA are discussed during this session. An overview of the recent evidence and consensus guiding evaluation are also presented.

Contact hours available until 11/3/2016.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Faculty, Planners and Authors Conflict of Interest Disclosure:
Planning Committee Disclosures:

Gina M. Powley, MSN, ANP-BC
Consultant: Ferring Pharmaceuticals, Astellas/Medivation

Leanne Schimke, MSN, CRNP-C, CUNP
Speaker's Bureau: Bayer-Xofigo, Amgen-Denosumab

There are no other disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
Society of Urologic Nurses and Associates is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

SUNA is a provider approved by the California Board of Registered Nursing, provider number, CEP 5556.

Objectives:

• State basic rationale for using & interpreting PSA and other biomarkers.
• Describe limitations of current approaches.
• Discuss epidemiology and possible prevention.

Speaker(s):

You must be logged in and own this session in order to post comments.